Claims for Patent: 12,576,072

Summary for Patent: 12,576,072

Title:	Liquid pharmaceutical composition
Abstract:	Described are oral, liquid pharmaceutical compositions that include sodium picosulfate, magnesium oxide, citric acid, and malic acid, and methods of making and using such compositions.
Inventor(s):	Bong Gil Nam, Byeung Jun Lee, Shunji Jin
Assignee:	Ferring International Center SA
Application Number:	US17/542,052
Patent Claims:	1. An oral, liquid pharmaceutical composition, prepared by a process comprising preparing a mixture comprising citric acid, magnesium oxide, malic acid, sodium picosulfate, a pH adjuster, and purified water, wherein the pharmaceutical composition has a pH in the range from 4.1 to 5.4, wherein the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of 0.003 to 0.009 sodium picosulfate:1 to 3 magnesium oxide:3.5 to 10.5 citric acid:0.01 to 13 malic acid. 2. The oral, liquid pharmaceutical composition of claim 1, wherein the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of about 0.005 sodium picosulfate:1.75 magnesium oxide:6 citric acid:4.19 malic acid. 3. The oral, liquid pharmaceutical composition of claim 1, wherein the pH adjuster comprises sodium hydroxide. 4. The oral, liquid pharmaceutical composition of claim 1, wherein the composition further comprises one or more of a sweetener and a fragrance ingredient. 5. The oral, liquid pharmaceutical composition of claim 1, wherein the composition further comprises acesulfame potassium. 6. The oral, liquid pharmaceutical composition of claim 1, wherein the composition further comprises disodium edetate. 7. The oral, liquid pharmaceutical composition of claim 1, wherein the composition further comprises sodium benzoate. 8. The oral, liquid pharmaceutical composition of claim 1, wherein the composition further comprises sucralose. 9. An oral, liquid pharmaceutical composition, comprising citric acid, magnesium oxide, malic acid, sodium picosulfate, sodium hydroxide, disodium edetate, sodium benzoate, and water, wherein the pharmaceutical composition has a pH in the range from 4.1 to 5.4, wherein the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of 0.003 to 0.009 sodium picosulfate:1 to 3 magnesium oxide:3.5 to 10.5 citric acid:0.01 to 13 malic acid. 10. The oral, liquid pharmaceutical composition of claim 9, wherein the composition further comprises acesulfame potassium. 11. The oral, liquid pharmaceutical composition of claim 10, wherein the composition further comprises sucralose. 12. The oral, liquid pharmaceutical composition of claim 9, wherein the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of about 0.005 sodium picosulfate:1.75 magnesium oxide:6 citric acid:4.19 malic acid. 13. The oral, liquid pharmaceutical composition of claim 9, wherein Substance A related to sodium picosulfate (4-[(pyridine-2-yl)(4-hydroxyphenyl) methyl]phenyl sodium sulfate) is generated in an amount of about 2.0 wt. % or less when the composition is left at room temperature for 24 months. 14. The oral, liquid pharmaceutical composition of claim 9, wherein precipitation occurs at about 5.0 vol. % or less when the composition is left at room temperature for 24 months. 15. A method of treatment for cleaning the colon of a subject in need thereof, comprising orally administering to the subject an effective amount of the oral liquid, pharmaceutical composition of claim 1. 16. The method of claim 15, wherein in the method is for pretreatment for colonoscopy, pretreatment for surgery, or pretreatment for surgery colon X-ray. 17. The method of claim 15, wherein, in the composition, the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of about 0.005 sodium picosulfate:1.75 magnesium oxide:6 citric acid:4.19 malic acid. 18. A method of treatment for cleaning the colon of a subject in need thereof, comprising orally administering to the subject an effective amount of the oral, liquid pharmaceutical composition of claim 9. 19. The method of claim 18, wherein in the method is for pretreatment for colonoscopy, pretreatment for surgery, or pretreatment for surgery colon X-ray. 20. The method of claim 18, wherein, in the composition, the sodium picosulfate, magnesium oxide, citric acid, and malic acid are present in a weight ratio of about 0.005 sodium picosulfate:1.75 magnesium oxide:6 citric acid:4.19 malic acid.